What option will be available for AML patients relapse after haploidentical SCT? 2nd alternative donor SCT or DLI or what else?
09:20-09:40
Hee-Je Kim
Department of Hematology, Catholic Blood and Marrow Transplantation Center, Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea